| 1. | Who has approved Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine, COVISHIELD, in India? |
|||||||
Answer: Option D Explanation: The Drugs Controller General of India (DCGI) has approved Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine, COVISHIELD, in India by the Serum Institute of India, Pune. The move is to hasten the development of the COVID-19 vaccine |
